The clinical utility of assessing ITPA genes includes identifying those individuals who are at the greatest risk of developing anemia, will help the patients to receive planned ribavirin dose with minimum side effects and identifying those who might tolerate a higher dose of ribavirin during treatment [8, 13–15]. Here, ITPA is linked to anemia (phenotype).